Latest Submitted Abstracts
ISR Autumn Meeting 2017
TBA PRESENTATION (17A119)
Speed of Onset of Effect on Patient- Reported Outcomes Assessed through Daily Electronic Patient Diaries in the Baricitinib Phase 3 RA Clinical Program
ISR Autumn Meeting 2017
TBA PRESENTATION (17A118)
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis: An Integrated Analysis
ISR Autumn Meeting 2017
TBA PRESENTATION (17A117)
Baricitinib Inhibits Radiographic Progression of Structural Joint Damage at 1 Year in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response to csDMARDs
ISR Autumn Meeting 2017
TBA PRESENTATION (17A116)
The National Centre For Paediatric Rheumatology (NCPR) Experience of the Use of Tocilizumab (Ro-Actemra) in the treatment of Juvenile Idiopathic Arthritis ( JIA ): A 7-Year Story
ISR Autumn Meeting 2017
TBA PRESENTATION (17A115)
The National Centre For Paediatric Rheumatology (NCPR) Experience of the Use of Tocilizumab (Ro-Actemra) in the treatment of Juvenile Idiopathic Arthritis ( JIA ): A 7-Year Story
ISR Autumn Meeting 2017
TBA PRESENTATION (17A114)
The Rheumatoid Arthritis Susceptibility Gene C5orf30 is an Immunomodulator in Macrophages
ISR Autumn Meeting 2017
TBA PRESENTATION (17A113)
High prevalence of sarcopenia in men with axial spondyloarthropathy
ISR Autumn Meeting 2017
TBA PRESENTATION (17A112)
Obesity predicts worse disease outcomes in axial spondyloarthropathy patients
ISR Autumn Meeting 2017
TBA PRESENTATION (17A111)
“Fast-tracking” a diagnosis of GCA
ISR Autumn Meeting 2017